
FDA & TGA Submission Services
eCTD Submission Services
IND, NDA, ANDA, BLA, 505(b)(2), DMF and ARTG dossiers — prepared, quality-reviewed and published in eCTD format for FDA and TGA lodgement. One team managing authoring, QA and eCTD publishing end-to-end.
IND · NDA · BLA · ANDA
FDA application types
CTD/eCTD
Dossier format expertise
FDA + TGA
Dual-agency submissions
QA-reviewed
Every submission
Application types
Every major FDA and TGA submission type
We manage submissions across the full range of FDA application types and TGA dossier formats — from first-in-human IND through to full marketing applications.
Investigational New Drug Application
Pre-clinical and Phase 1 through Phase 3 IND submissions, amendments and annual reports.
New Drug Application
Full 505(b)(1) NDA and 505(b)(2) applications — all CTD modules authored, QA-reviewed and eCTD-published.
Abbreviated New Drug Application
Generic drug submissions including bioequivalence documentation, labeling and eCTD formatting.
Biologics License Application
BLA submissions for biologics and biosimilars — complex multi-module dossiers managed end-to-end.
505(b)(2) Application
Hybrid applications relying on published literature or prior FDA findings — bridging strategy and submission.
Drug Master File
Type II and Type III DMF preparation and annual updates for API and excipient manufacturers.
Australian Register of Therapeutic Goods
Full CTD/eCTD dossiers for TGA prescription and OTC medicine registrations.
Medical Device Submissions
510(k), De Novo and ARTG device dossiers formatted and lodged to agency standards.
Our process
From gap analysis to lodgement
Gap analysis
We review your data package against the target agency's current guidance and identify missing or deficient elements before authoring begins.
Module authoring
Our consultants author or co-author CTD modules — CMC, nonclinical and clinical overviews — with cross-module consistency built in from the start.
Internal QA review
Every submission goes through a structured quality review: scientific consistency across modules, formatting against agency guidance, completeness check.
eCTD publishing
We publish the validated eCTD sequence using current publishing tools, verify the XML backbone, run validation checks and produce a submission-ready package.
Lodgement and tracking
We lodge the submission with FDA or TGA and track it through the review process — managing information requests and maintaining submission history.
Ready to submit?
Get your submission right the first time
A poorly prepared submission costs months. Book a free consultation and we will assess your data package and outline the submission plan.
